Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07706348Phase 2Recruiting
Phase 2, randomised trial of ondansetron in acute postoperative pain (2 arms), sponsored by Assiut University. Primary endpoint: Total Morphine Consumption at 24 hours. Started Jun 2026; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07706348.